JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A1435 CP-945598 HCl

Summary: CB1 antagonist,selective and high affinity

≥27.35 mg/mL
A1605 Dynasore
4 Citation

Target: GTPases

Summary: Dynamin and GTPase inhibitor

insoluble in H2O; insoluble in EtOH; ≥16.12 mg/mL
A1615 GANT61
1 Citation

Target: GLI

Summary: GLI antagonist
A1952 NSC23766 trihydrochloride
5 Citation

Summary: Selective inhibitor of Rac1-GEF interaction.

≥26.55 mg/mL
A1655 GW2580
1 Citation

Target: CSF-1R

Summary: CFMS kinase/CSF-1R inhibitor,selective and ATP-competitive

≥36.6 mg/mL
A1709 GW9508

Target: Free Fatty Acid Receptors

Summary: FFA1/GPR40 agonist,potent and selective

insoluble in H2O; ≥16.05 mg/mL
A2025 Plerixafor (AMD3100)
8 Citation

Summary: CXCR4 chemokine receptor antagonist

≥25.14 mg/mL
A2033 PQ 401
1 Citation

Summary: IGF1R inhibitor,potent and cell-permeable

insoluble in H2O; ≥17.1 mg/mL
A2323 TCS 359

Summary: Potent FLT3 inhibitor

insoluble in EtOH; insoluble in H2O; ≥9 mg/mL
A1986 Nu 6027

Target: Cyclin-Dependent Kinases|ATM/ATR

Summary: ATR/CDK inhibitor, potent and selective

insoluble in H2O; ≥12.55 mg/mL